Press releases
- Taro to Release Full Year Results on May 20, 2024
- Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger
- Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Key statistics
On Tuesday, Taro Pharmaceutical Industries Ltd (TAL:STU) closed at 38.60, -3.98% below its 52-week high of 40.20, set on Jan 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 38.60 |
---|---|
High | 38.80 |
Low | 38.60 |
Bid | 38.60 |
Offer | 39.80 |
Previous close | 38.60 |
Average volume | 0.00 |
---|---|
Shares outstanding | 37.58m |
Free float | 8.08m |
P/E (TTM) | 34.81 |
Market cap | 1.59bn USD |
EPS (TTM) | 1.22 USD |
Data delayed at least 15 minutes, as of May 14 2024.
More ▼